FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968296705> ?p ?o ?g. }

• W2968296705 endingPage "5342" @default.
• W2968296705 startingPage "5342" @default.
• W2968296705 abstract "Klotho is an anti-aging transmembrane protein, which is expressed in the brain and kidney, and also in various endocrine-related tissues including the pancreas. We have recently identified klotho as a tumor suppressor and a modulator of the insulin-like growth factor (IGF)-1 and the fibroblast growth factor (FGF) pathways in breast cancer. Pancreatic adenocarcinoma is one of the most lethal of human cancers, with less than 5% 5-year survival. The IGF-1 pathway plays an important role in the pathogenesis of pancreatic cancer. IGF-I and IGF-I receptor (IGF-IR) are overexpressed in human pancreatic tumors and cell lines. Inhibition of the IGF-1R suppresses tumorigenicity in vitro and in vivo and increases sensitivity of pancreatic tumors to radiation and chemotherapy-induced apoptosis. Thus, the IGF pathway may serve as an attractive target for novel therapies against pancreatic cancer. As klotho inhibits the IGF-I pathway and is expressed in normal pancreas, we aimed to study its expression and activities in pancreatic cancer. Immunohistochemistry was used to analyze klotho expression in pancreatic tissues and revealed high klotho expression in normal pancreas, but only in 2 out of 12 pancreatic cancer samples. Overexpression of klotho markedly reduced colony formation and proliferation of Panc1, Colo357 and Mia-PaCa2 pancreatic cancer cell lines, but not of the human non-cancer cells, HEK-293 and treatment of Panc1 cells with soluble klotho (5nM) caused a reduction of more than 50% in cell viability. Moreover, soluble klotho increased Panc1 sensitivity to the chemotherapeutic drug 5-fluorouracil (5-FU). While 5-FU alone reduced viability by 50%, the combination reduced viability by 75%. Both overexpressed and soluble klotho inhibited ligand-dependent activation of IGF-I pathway in pancreatic cancer cells, resulting in reduced phosphorylation of the IGF-IR and its downstream targets IRS-1, AKT1, ERK1/2. The in vivo activity of klotho was tested using a xenograft model. Panc1 cells were injected into both flanks of athymic mice and treated with daily intraperitoneal injections of either a control vehicle, 10µg/kg or 25µg/kg soluble klotho (5 mice in each group). Treatment reduced tumor size by 30% to 50% respectively. Notably, klotho administration did not affect weight or general health of the mice. Our data indicate klotho, for the first time, as a potential tumor suppressor gene in pancreatic cancer. Klotho levels are reduced in pancreatic cancer and expression of it in pancreatic cancer cells, or treatment with its soluble form, slows their growth and inhibits the IGF-1 pathway. Moreover, daily treatment of mice with soluble klotho was safe and effectively reduced growth of pancreatic cancer cells. As klotho is an endogenous hormone, its use as a novel therapeutic model may be feasible and should be further explored. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 5342." @default.
• W2968296705 created "2019-08-22" @default.
• W2968296705 creator A5035450363 @default.
• W2968296705 creator A5035921078 @default.
• W2968296705 creator A5048131884 @default.
• W2968296705 creator A5059302541 @default.
• W2968296705 creator A5062850935 @default.
• W2968296705 creator A5083392542 @default.
• W2968296705 date "2009-05-01" @default.
• W2968296705 modified "2023-09-27" @default.
• W2968296705 title "Abstract #5342: The aging suppressor klotho: A tumor suppressor and modulator of the IGF-I pathway in human pancreatic cancer" @default.
• W2968296705 hasPublicationYear "2009" @default.
• W2968296705 type Work @default.
• W2968296705 sameAs 2968296705 @default.
• W2968296705 citedByCount "0" @default.
• W2968296705 crossrefType "journal-article" @default.
• W2968296705 hasAuthorship W2968296705A5035450363 @default.
• W2968296705 hasAuthorship W2968296705A5035921078 @default.
• W2968296705 hasAuthorship W2968296705A5048131884 @default.
• W2968296705 hasAuthorship W2968296705A5059302541 @default.
• W2968296705 hasAuthorship W2968296705A5062850935 @default.
• W2968296705 hasAuthorship W2968296705A5083392542 @default.
• W2968296705 hasConcept C121608353 @default.
• W2968296705 hasConcept C126322002 @default.
• W2968296705 hasConcept C134018914 @default.
• W2968296705 hasConcept C2778764654 @default.
• W2968296705 hasConcept C2780091579 @default.
• W2968296705 hasConcept C2780210213 @default.
• W2968296705 hasConcept C502942594 @default.
• W2968296705 hasConcept C71924100 @default.
• W2968296705 hasConcept C86803240 @default.
• W2968296705 hasConcept C9832595 @default.
• W2968296705 hasConceptScore W2968296705C121608353 @default.
• W2968296705 hasConceptScore W2968296705C126322002 @default.
• W2968296705 hasConceptScore W2968296705C134018914 @default.
• W2968296705 hasConceptScore W2968296705C2778764654 @default.
• W2968296705 hasConceptScore W2968296705C2780091579 @default.
• W2968296705 hasConceptScore W2968296705C2780210213 @default.
• W2968296705 hasConceptScore W2968296705C502942594 @default.
• W2968296705 hasConceptScore W2968296705C71924100 @default.
• W2968296705 hasConceptScore W2968296705C86803240 @default.
• W2968296705 hasConceptScore W2968296705C9832595 @default.
• W2968296705 hasLocation W29682967051 @default.
• W2968296705 hasOpenAccess W2968296705 @default.
• W2968296705 hasPrimaryLocation W29682967051 @default.
• W2968296705 hasRelatedWork W2013084670 @default.
• W2968296705 hasRelatedWork W2022932085 @default.
• W2968296705 hasRelatedWork W2025523656 @default.
• W2968296705 hasRelatedWork W2030507184 @default.
• W2968296705 hasRelatedWork W2108944327 @default.
• W2968296705 hasRelatedWork W2112489161 @default.
• W2968296705 hasRelatedWork W2152772600 @default.
• W2968296705 hasRelatedWork W2283790305 @default.
• W2968296705 hasRelatedWork W2321084168 @default.
• W2968296705 hasRelatedWork W2330186804 @default.
• W2968296705 hasRelatedWork W2333677280 @default.
• W2968296705 hasRelatedWork W2428924377 @default.
• W2968296705 hasRelatedWork W2564418272 @default.
• W2968296705 hasRelatedWork W2584060826 @default.
• W2968296705 hasRelatedWork W2768679607 @default.
• W2968296705 hasRelatedWork W2794827677 @default.
• W2968296705 hasRelatedWork W2907041778 @default.
• W2968296705 hasRelatedWork W2971262121 @default.
• W2968296705 hasRelatedWork W2996217572 @default.
• W2968296705 hasRelatedWork W3093726628 @default.
• W2968296705 hasVolume "69" @default.
• W2968296705 isParatext "false" @default.
• W2968296705 isRetracted "false" @default.
• W2968296705 magId "2968296705" @default.
• W2968296705 workType "article" @default.